BG106583A - Diagnosis of a person's risk of developing alcoholism - Google Patents
Diagnosis of a person's risk of developing alcoholismInfo
- Publication number
- BG106583A BG106583A BG106583A BG10658302A BG106583A BG 106583 A BG106583 A BG 106583A BG 106583 A BG106583 A BG 106583A BG 10658302 A BG10658302 A BG 10658302A BG 106583 A BG106583 A BG 106583A
- Authority
- BG
- Bulgaria
- Prior art keywords
- risk
- person
- alcoholism
- development
- diagnosis
- Prior art date
Links
- 208000007848 Alcoholism Diseases 0.000 title abstract 3
- 201000007930 alcohol dependence Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 238000010171 animal model Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57545—Neuropeptide Y
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21932400P | 2000-03-21 | 2000-03-21 | |
| PCT/FI2001/000103 WO2001071029A1 (en) | 2000-03-21 | 2001-02-06 | Diagnosis of a person's risk of developing alcoholism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG106583A true BG106583A (en) | 2003-04-30 |
Family
ID=22818825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG106583A BG106583A (en) | 2000-03-21 | 2002-04-05 | Diagnosis of a person's risk of developing alcoholism |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030224362A1 (xx) |
| EP (1) | EP1266029A1 (xx) |
| JP (1) | JP2003527865A (xx) |
| AU (1) | AU3381801A (xx) |
| BG (1) | BG106583A (xx) |
| BR (1) | BR0107845A (xx) |
| CA (1) | CA2383848A1 (xx) |
| CZ (1) | CZ20022469A3 (xx) |
| EE (1) | EE200200416A (xx) |
| HU (1) | HUP0301944A2 (xx) |
| NO (1) | NO20021378D0 (xx) |
| NZ (1) | NZ517908A (xx) |
| PL (1) | PL362862A1 (xx) |
| SK (1) | SK4212002A3 (xx) |
| WO (1) | WO2001071029A1 (xx) |
| ZA (1) | ZA200201868B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0807421D0 (en) * | 2008-04-23 | 2008-05-28 | Ucl Business Plc | Markers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6046317A (en) * | 1997-12-19 | 2000-04-04 | Hormos Medical Oy, Ltd. | DNA molecule encoding a mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| US6312898B1 (en) * | 1999-04-15 | 2001-11-06 | Hormos Medical Oy, Ltd. | Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene |
-
2001
- 2001-02-06 PL PL01362862A patent/PL362862A1/xx not_active Application Discontinuation
- 2001-02-06 BR BR0107845-3A patent/BR0107845A/pt not_active Application Discontinuation
- 2001-02-06 CA CA002383848A patent/CA2383848A1/en not_active Abandoned
- 2001-02-06 EE EEP200200416A patent/EE200200416A/xx unknown
- 2001-02-06 CZ CZ20022469A patent/CZ20022469A3/cs unknown
- 2001-02-06 WO PCT/FI2001/000103 patent/WO2001071029A1/en not_active Ceased
- 2001-02-06 EP EP01905842A patent/EP1266029A1/en not_active Withdrawn
- 2001-02-06 US US10/069,129 patent/US20030224362A1/en not_active Abandoned
- 2001-02-06 JP JP2001569409A patent/JP2003527865A/ja active Pending
- 2001-02-06 AU AU33818/01A patent/AU3381801A/en not_active Abandoned
- 2001-02-06 SK SK421-2002A patent/SK4212002A3/sk unknown
- 2001-02-06 HU HU0301944A patent/HUP0301944A2/hu unknown
- 2001-02-06 NZ NZ517908A patent/NZ517908A/en unknown
-
2002
- 2002-03-06 ZA ZA200201868A patent/ZA200201868B/xx unknown
- 2002-03-20 NO NO20021378A patent/NO20021378D0/no unknown
- 2002-04-05 BG BG106583A patent/BG106583A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20022469A3 (cs) | 2002-10-16 |
| HUP0301944A2 (hu) | 2003-09-29 |
| NO20021378L (no) | 2002-03-20 |
| PL362862A1 (en) | 2004-11-02 |
| JP2003527865A (ja) | 2003-09-24 |
| NZ517908A (en) | 2003-07-25 |
| CA2383848A1 (en) | 2001-09-27 |
| ZA200201868B (en) | 2003-03-06 |
| AU3381801A (en) | 2001-10-03 |
| US20030224362A1 (en) | 2003-12-04 |
| NO20021378D0 (no) | 2002-03-20 |
| BR0107845A (pt) | 2002-10-22 |
| WO2001071029A1 (en) | 2001-09-27 |
| SK4212002A3 (en) | 2002-11-06 |
| EP1266029A1 (en) | 2002-12-18 |
| EE200200416A (et) | 2003-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brogden et al. | Device for the motor conditioning of small animals | |
| EP1229954A4 (en) | Method of treating cardio pulmonary diseases with no group compounds | |
| WO2003078658A3 (en) | Methods for diagnosing and treating schizophrenia | |
| DE60331941D1 (de) | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert | |
| WO2003040964A3 (en) | Patient data mining for diagnosis and projections of patient states | |
| PL350620A1 (en) | Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy | |
| WO2001058476A3 (en) | Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity | |
| WO2004010927A3 (en) | Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes | |
| AU2003217652A8 (en) | Methods for continuous performance testing | |
| WO2003004045A3 (en) | Methods for identifying therapeutic agents for treating diseases involving wnt polypeptides and wnt receptors | |
| WO2004107958A3 (en) | Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | |
| DE60122673D1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
| BG106583A (en) | Diagnosis of a person's risk of developing alcoholism | |
| DE60311433D1 (de) | Spheron-komponenten für die bestimmung von verbindungen, die symptome der alzheimer krankheit behandeln können, ihre behandlungen und tiermodelle | |
| DE602004026683D1 (de) | Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins | |
| WO2004036221A3 (en) | Compositions and methods for diagnosing and treating autoimmune disease | |
| EP1363528A4 (en) | METHODS OF DIAGNOSING AND TREATING CARDIOPATHIES | |
| SI1292187T1 (sl) | Transgenski zivalski model nevrodegenerativnih motenj | |
| Service et al. | The invisible barrier: literacy and its relationship with oral health. A report of a workgroup sponsored by the National Institute of Dental and Craniofacial Research, National Institute of Health, US Public Health Service, Department of Health and Human Services | |
| WO2004074514A3 (en) | Method of diagnosis of type 2 diabetes and early onset thereof | |
| ATE397090T1 (de) | Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen | |
| ATE389418T1 (de) | Abbilden der dopamintransporter zur bestimmung des ad-hd | |
| BR8101623U (pt) | Disposição introduzida em filtro para cobertura de piscinas | |
| WO2003050300A3 (en) | Diagnosis and treatment of cancer | |
| UA36589C2 (en) | Method for predicting efficacy of alcoholism treatment according to o.r. dovzhenko's technique |